Data Bridge Market Research analyses that the active pharmaceutical ingredient (API) market is expected to reach USD 369.56 million by 2030, which is USD 223.3 million in 2022, and is expected to undergo a CAGR of 6.50% during the forecast period 2023 to 2030.
Get sample of the report
Market Players Covered
Novartis AG (Switzerland), Sanofi (France). Pfizer Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Bausch Health Companies Inc. (Canada), UCB S.A. (Belgium), Sunovion Pharmaceuticals Inc. (U.S.), Jazz Pharmaceuticals, Inc. (U.K.), AstraZeneca (U.K.), GSK plc (U.K.), H. Lundbeck A/S (Denmark), Takeda Pharmaceutical Company Limited (Japan), Sumitomo Dainippon Pharma Co., Ltd. (Japan), Cadila Pharmaceuticals (India)
Active Pharmaceutical Ingredient (API) Market Analysis and Insights
The active pharmaceutical ingredient (API) is a drug's active component. In layman's terms, API is a component of any drug that produces the desired effects. Drugs are typically made up of several components. The primary ingredient is the API. Excipients are other ingredients that are required to be biologically innocuous and often form a changeable fraction of the drug product. Formulation refers to optimizing and composing the mixture of ingredients used in medicine. Some drugs contain multiple active APIs in order to treat multiple symptoms or act in complex ways. Local pharmaceutical companies have done the majority of API production.
Global Active Pharmaceutical Ingredient (API) Market Scope
The active pharmaceutical ingredient (API) market is segmented on the basis of molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency and therapeutic application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Molecule
- Small molecule
- Large molecule
Type
- Innovative Active Pharmaceutical Ingredients
- Generic Active Pharmaceutical Ingredients
Type of manufacturer
- Captive API Manufacturer
- Merchant API Manufacturer
Synthesis
- Synthetic Active Pharmaceutical Ingredients
- Biotech Active Pharmaceutical Ingredients
Indications
- Acetaminophen
- Artemisinin
- Saxagliptin
- Sodium Chloride
- Ibuprofen Losartan Potassium
- Enoxaparin Sodium
- Rufinamide
- Naproxen
- Tamoxifen
- Others
Type of drugs
- prescription drugs
- over the counter drugs
Usage
- clinical
- research
Potency
- low-to-moderate potency active pharmaceutical ingredients
- potent-to-highly potent active pharmaceutical ingredient
Therapeutic application
- cardiology
- CNS & neurology
- Oncology
- Orthopaedic
- Endocrinology
- Pulmonology
- Gastroenterology
- Nephrology
- Ophthalmology
- other therapeutic application
Active Pharmaceutical Ingredient (API) Market Share Analysis
The active pharmaceutical ingredient (API) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to active pharmaceutical ingredient (API) market.
Key players of Active Pharmaceutical Ingredient (API) Market
Some of the major players operating in the active pharmaceutical ingredient (API) market are
- Novartis AG (Switzerland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Abbott (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bausch Health Companies Inc. (Canada)
- UCB S.A. (Belgium)
- Sunovion Pharmaceuticals Inc. (U.S.)
- GW Pharmaceuticals plc. (U.K.)
- AstraZeneca (U.K.)
- GlaxoSmithKline plc (U.K.)
- Lundbeck A/S (Denmark)
- Takeda Pharmaceutical Company Limited (Japan)
- Sumitomo Dainippon Pharma Co., Ltd. (Japan)
- Cadila Pharmaceuticals (India)
Get Full Access to Report @
https://www.databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: Active Pharmaceutical Ingredient (API) Market
Get TOC Details
Browse Related Reports@
https://www.databridgemarketresearch.com/reports/global-cloud-erp-market
https://www.databridgemarketresearch.com/reports/global-party-supplies-market
https://www.databridgemarketresearch.com/reports/global-stainless-steel-water-bottle-market
https://www.databridgemarketresearch.com/reports/global-sleep-tech-devices-market
https://www.databridgemarketresearch.com/reports/north-america-edible-oils-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
